The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly credit the many pro-consumer benefits of hospital transactions, and ignores key realities of the marketplace,” according to an analysis submitted to the agency Friday for a series of FTC hearings on Competition and Consumer Protection in the 21st Century. Performed for the AHA by Charles River Associates in conjunction with antitrust counsel at Wilson Sonsini Goodrich & Rosati, the analysis describes “serious flaws” in the supply and demand models that the FTC uses to evaluate the competitive effects of hospital transactions. “The Commission’s approach has substantial negative ramifications for U.S. consumers,” AHA said. “These include impeding the ability of hospitals and health care systems to develop more efficient platforms to care for tens of millions of Americans. The FTC’s approach also is placing hospitals at a serious disadvantage relative to the many new entrants to health care.”

Related News Articles

Headline
Community Health Improvement Week (June 1-5) celebrates people coming together to create healthier communities. And that's never been more important than now…
Headline
Thirty-three emerging hospital and health system leaders from 20 states will participate in the inaugural class of the AHA’s Next Generation Leaders Fellowship…
Headline
The AHA today debuted a new video that spotlights the value of membership in the AHA, including how the association is telling hospital and health systems’…
Headline
Employment at the nation's hospitals fell by 2.6% in April to a seasonally adjusted 5,130,000 people, the Bureau of Labor Statistics reported today. That's 134…
Headline
The AHA has been featured in numerous media publications, including the Washington Post, Wall Street Journal, Politico and Modern Healthcare, for various COVID…
Headline
President Trump yesterday suspended new immigrant visas for 60 days, exempting medical and other essential workers combating the COVID-19 emergency.